Shi Du

410 total citations
7 papers, 307 citations indexed

About

Shi Du is a scholar working on Biomedical Engineering, Molecular Biology and Biomaterials. According to data from OpenAlex, Shi Du has authored 7 papers receiving a total of 307 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Biomedical Engineering, 3 papers in Molecular Biology and 3 papers in Biomaterials. Recurrent topics in Shi Du's work include Nanoparticle-Based Drug Delivery (3 papers), Nanoplatforms for cancer theranostics (3 papers) and Peptidase Inhibition and Analysis (2 papers). Shi Du is often cited by papers focused on Nanoparticle-Based Drug Delivery (3 papers), Nanoplatforms for cancer theranostics (3 papers) and Peptidase Inhibition and Analysis (2 papers). Shi Du collaborates with scholars based in China, Bulgaria and United States. Shi Du's co-authors include Jing Yao, Hui Xiong, Jianping Zhou, Ni Jiang, Cheng Xu, Yun Lu, Zhijie Jiang, Ping Zhang, Shan Yang and Yan Xiao and has published in prestigious journals such as Biomaterials, Journal of Controlled Release and Drug Discovery Today.

In The Last Decade

Shi Du

5 papers receiving 305 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shi Du China	5	204	154	116	45	35	7	307
Pouya Dehghankelishadi Australia	7	116 0.6×	154 1.0×	131 1.1×	59 1.3×	28 0.8×	14	319
Ezgi Özliseli Finland	9	163 0.8×	136 0.9×	123 1.1×	72 1.6×	66 1.9×	14	379
Chuanyou Guo China	6	201 1.0×	192 1.2×	195 1.7×	33 0.7×	53 1.5×	7	392
Larissa Bueno Tofani Brazil	10	172 0.8×	135 0.9×	134 1.2×	25 0.6×	53 1.5×	15	392
Wang-Wei Guo China	8	192 0.9×	197 1.3×	174 1.5×	35 0.8×	36 1.0×	10	350
Ming-Yi Huang-Fu China	8	233 1.1×	241 1.6×	168 1.4×	43 1.0×	28 0.8×	8	398
Indra Van Zundert Belgium	7	142 0.7×	106 0.7×	107 0.9×	40 0.9×	40 1.1×	10	293
Shuaishuai Feng China	7	275 1.3×	244 1.6×	208 1.8×	54 1.2×	54 1.5×	10	462
Maximilian Regenold Canada	9	246 1.2×	176 1.1×	116 1.0×	36 0.8×	50 1.4×	12	410

Countries citing papers authored by Shi Du

Since Specialization

Citations

This map shows the geographic impact of Shi Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shi Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shi Du more than expected).

Fields of papers citing papers by Shi Du

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shi Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shi Du. The network helps show where Shi Du may publish in the future.

Co-authorship network of co-authors of Shi Du

This figure shows the co-authorship network connecting the top 25 collaborators of Shi Du. A scholar is included among the top collaborators of Shi Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shi Du. Shi Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Jiang, Zewei, Zunfu Ke, Liang Zhang, et al.. (2025). Nanodrug-based therapeutic interventions for tumor-associated microbiota modulation. Journal of Controlled Release. 387. 114196–114196.

2.

Du, Shi, et al.. (2019). LMWH and its derivatives represent new rational for cancer therapy: construction strategies and combination therapy. Drug Discovery Today. 24(10). 2096–2104. 29 indexed citations

3.

Du, Shi, Hui Xiong, Cheng Xu, Yun Lu, & Jing Yao. (2019). Attempts to strengthen and simplify the tumor vascular normalization strategy using tumor vessel normalization promoting nanomedicines. Biomaterials Science. 7(3). 1147–1160. 55 indexed citations

4.

Xiao, Yan, Cheng Xu, Hui Xiong, et al.. (2018). Dose-reduction antiangiogenic curcumin-low molecular weight heparin nanodrugs for enhanced combinational antitumor therapy. European Journal of Pharmaceutical Sciences. 119. 121–134. 16 indexed citations

5.

Xiong, Hui, Shi Du, Ping Zhang, et al.. (2018). Primary tumor and pre-metastatic niches co-targeting “peptides-lego” hybrid hydroxyapatite nanoparticles for metastatic breast cancer treatment. Biomaterials Science. 6(10). 2591–2604. 36 indexed citations

6.

Xiong, Hui, Shi Du, Ni Jiang, Jianping Zhou, & Jing Yao. (2016). Mitochondria and nuclei dual-targeted heterogeneous hydroxyapatite nanoparticles for enhancing therapeutic efficacy of doxorubicin. Biomaterials. 94. 70–83. 171 indexed citations

7.

Du, Shi, et al.. (2013). Study on Biological Materials with Genetic Diversity of <i>Bupleurum marginatum</i> in Northwest of Hubei Province of China Base on ISSR. Advanced materials research. 830. 463–468.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact